Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Rapaflo Generic Name & Formulations
Legal Class
Rx
General Description
Silodosin 4mg, 8mg; caps.
Pharmacological Class
Alpha-1 blocker.
How Supplied
Caps—30, 90
Manufacturer
Generic Availability
YES
Rapaflo Indications
Indications
Benign prostatic hyperplasia.
Rapaflo Dosage and Administration
Adult
Take with food once daily. Normal renal function: 8mg. Renal impairment (CrCl 30–50mL/min): 4mg. Difficulty swallowing pills/caps: may open caps and sprinkle contents on a tablespoonful of applesauce; swallow immediately (within 5mins) without chewing and follow with an 8oz glass of water.
Children
Not established.
Rapaflo Contraindications
Contraindications
Severe renal impairment (CrCl <30mL/min). Severe hepatic impairment (Child-Pugh score ≥10). Concomitant potent CYP3A4 inhibitors (eg, ketoconazole, itraconazole, clarithromycin, ritonavir).
Rapaflo Boxed Warnings
Not Applicable
Rapaflo Warnings/Precautions
Warnings/Precautions
Not for treating hypertension. Exclude prostate cancer. Anticipated cataract surgery (may cause intraoperative floppy iris syndrome; advise ophthalmologist). Pregnancy, nursing mothers: not indicated for use in females.
Rapaflo Pharmacokinetics
Elimination
Fecal, renal.
Rapaflo Interactions
Interactions
See Contraindications. Concomitant other α-blockers, other strong P-glycoprotein inhibitors (eg, cyclosporine): not recommended. May be potentiated by moderate CYP3A4 inhibitors (eg, erythromycin, diltiazem, verapamil). Caution with other antihypertensives or PDE-5 inhibitors.
Rapaflo Adverse Reactions
Adverse Reactions
Retrograde ejaculation, dizziness, diarrhea, orthostatic hypotension, headache, nasopharyngitis, nasal congestion.
Rapaflo Clinical Trials
See Literature
Rapaflo Note
Not Applicable
Rapaflo Patient Counseling
See Literature
Images
